Olympus Corporation of the Americas Olympus Pleuravideoscope, Model LTF-160 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Olympus Pleuravideoscope, Model LTF-160
Brand
Olympus Corporation of the Americas
Lot Codes / Batch Numbers
All Serial numbers
Products Sold
All Serial numbers
Olympus Corporation of the Americas is recalling Olympus Pleuravideoscope, Model LTF-160 due to There was no data to validate that the identified endo-therapy devices were compatible with certain pleuravideoscope models. Updated Operations Manua. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
There was no data to validate that the identified endo-therapy devices were compatible with certain pleuravideoscope models. Updated Operations Manuals are being provided.
Recommended Action
Per FDA guidance
An Urgent Medical Device Correction notification letter dated 3/23/20 was sent to customers. Actions to be taken by the user: Our records indicate that your facility has purchased one or more of the above-referenced endoscopes. OLYMPUS requires that you take the following actions: a) Inspect your inventory of operation manuals for the referenced Olympus models and discard the existing ones. b) Exchange them with the updated, enclosed Operation Manuals having an updated system chart indicating compatible endoscope accessories. c) Notify related personnel at your institution that they should stop the combination use of the LTF-160 and LTF-240 and the subject Endo-Therapy accessories. d) Access the Olympus recall portal to indicate that you have received this notification. Go to https://olympusamerica.com/recall. Enter the recall number Recall-0066 and provide your contact information as indicated in the portal. e) If you have further distributed this product, identify your customers, forward them this notification including the attachments, and appropriately document your notification process. Olympus regrets any inconvenience caused and fully appreciates your prompt cooperation in addressing this situation. If you require additional information, please do not hesitate to contact me directly at (484)896-5688 from Monday till Friday 8AM ET to 5PM ET or by e-mail at laura.storms@olympus.com.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026